|
Match
|
Document |
Document Title |
|
|
4619827 |
Method for administering equine vaccines and compositions therefor
A method for enhancing a vaccine immune response in equines using leukokines, particularly mixed leucokines, is described. The leukokines can be administered separately or admixed with the vaccine....
|
|
|
4618494 |
Human Immune Factors and processes for their production and use
Type 1 Diabetes and other virus-induced or autoimmunological diseases are treated with Human Immune Factors. These Human Immune Factors are extracted from blood cells by activating said blood cells...
|
|
|
4609546 |
Long-acting composition
A composition wherein a physiologically active polypeptide or a glycoprotein of human origin, for instance, urokinase, kallikrein or leukocyte interferon, is coupled to a...
|
|
|
4534906 |
Removal of impurities from human leukocyte interferon preparations
Disclosed is a method for removing impurities from leukocyte interferon preparations involving use of a unique incubation procedure.
|
|
|
4530787 |
Controlled oxidation of microbially produced cysteine-containing proteins
Method of oxidizing reduced cysteine-containing microbially produced synthetic proteins, such as synthetic IFN-β or synthetic IL-2, in a controlled manner so that the synthetic proteins have the...
|
|
|
4526782 |
Process for recovering interferon
Interferon can be recovered simply by contacting an aqueous solution containing interferon which is induced and produced from cells of human origin capable of producing interferon, with a siliceous...
|
|
|
4507281 |
Interferon-containing compositions
A composition for treating herpes simplex viral infections in humans is disclosed, comprising about 10 2 to 10 8 I.U. of human interferon, about 0.1% to 20% by weight of an antiviral surface...
|
|
|
4503035 |
Protein purification process and product
An improved process for purifying proteins, particularly proteins having molecular weights in excess of 12,000 involves novel applications of high performance liquid chromatography on a preparative...
|
|
|
4499072 |
Process for treating diseases with ODC inhibitors
This invention relates to the improvement of the polyamine depletion effects of ornithine decarboxylase inhibitors and/or S-adenosylmethionine decarboxylase inhibitors, the improvement being...
|
|
|
4496537 |
Biologically stable alpha-interferon formulations
The addition of glycine or alanine prior to lyophilization significantly improves the biological stability of alpha type interferon formulations.
|
|
|
4485038 |
Method for the production and purification of human leukocyte interferon
A process for the production and purification of human interferon derived from leukocyte of lymphoblastoid cell origin characterized by a sequence of steps involving chromatography of a solution of...
|
|
|
4480032 |
Natural mixture of Type I and Type II interferons
Pharmaceutical compositions comprising a natural mixture of Type I and Type II interferons which are produced by induction with measles vaccine virus in leukocyte cells obtained from human donors...
|
|
|
4462986 |
Synergistic anti-herpes compositions
Combinations of 9-[[2-hydroxy-1-(hydroxymethyl)-ethoxy]methyl]guanine or a pharmaceutically acceptable salt thereof, and interferon show synergy in their activity against herpes virus infections.
|
|
|
4461757 |
Dimethylaminomethylenated anti-herpes compounds
2-(N,N-dialkylaminomethylene)-9-[[2-hydroxy-1-(hydroxymethyl
)-ethoxy]methyl ]guanine either alone or in admixture with interferon is active in treatment of herpes simplex type 1 viral infections.
|
|
|
4460574 |
Prophylaxis or treatment of interferon-sensitive diseases
Prophylaxis or treatment of interferon-sensitive diseases in a human is effected by the rectal or urogenital administration to a human of a liquid pharmaceutical composition of native human...
|
|
|
4432895 |
Monomeric interferons
A method for producing monomeric interferons from oligomeric interferons, for preventing formation of oligomeric interferon from monomeric interferon, and for increasing the yield of monomeric...
|
|
|
4420398 |
Filteration method for cell produced antiviral substances
This invention affords a filtration method and apparatus for extracting cell produced antiviral substances (CPAS) from a production broth using cross-flow membrane filtration. The broth is perfused...
|
|
|
4370312 |
Decapeptide
The decapeptide of the formula H-Ser-Asp-Leu-Pro-Gln-Thr-His-Ser-Leu-Gly-OH and the use thereof as hapten, tracer or antibody.
|
|
|
4364863 |
Extraction of interferon from bacteria
A method of extracting leucocyte interferon from interferon-expressing bacterial cells comprising acidifying a suspension of interferon-containing bacterial cells, removing substantially all of the...
|
|
|
4362155 |
Method and apparatus for the treatment of autoimmune and allergic diseases
A method and apparatus for the treatment of autoimmune diseases and allergy (hypersensitivity of immediate type). The apparatus ulitizes an absorption system to absorb interferon from whole blood,...
|
|
|
4328207 |
Process for preparing mouse interferon
The present invention relates to a process which is easily applicable for industrial production of mouse interferon. Particularly, the present invention relates to a process based on the discovery...
|
|
|
4276282 |
Interferon and preparations containing interferon
The present invention relates to processes for an easily applicable industrial production of interferon and the possibilities of the products for preventing and treating interferonsensitive...
|
|
|
4273703 |
Interferon product and process for its preparation
Exogenic porcine interferon for administration in human beings. The porcine interferon shows antiviral protecting activity on cultured human cells and is substantially free of any...
|
|
|
4266024 |
Process for the production of human interferon
This invention is directed to a process of producing interferon which comprises incubating permanent cell lines of lymphoblast origin or human fibroblast cells with interferon inducers and...
|
|
|
4252791 |
Interferon stabilization
The loss of biological activity of interferons is prevented or reduced by the addition of soluble lanthanide or calcium salts.
|
|
|
4241174 |
Interferon assay
A rapid cytopathic effect inhibition assay for interferon is disclosed. The assay can be completed in about 16 hours or less, allowing its use to assist in clinical diagnosis of viral infections...
|
|
|
3660564 |
Title is not available
|
|
|
3560611 |
Title is not available
|